YouScript, a life-saving clinical decision support tool, aiding enterprise health solution providers in reducing the adverse drug event epidemic.
Seattle, WA — (July 26, 2017) — YouScript is now a verified company with HealthXL , a global organization driving innovation in healthcare through an elite network of healthcare executives and global solutions. Companies can only obtain verified status when there is evidence that their product has a positive clinical or commercial impact. YouScript is a disruptive technology tackling the monumental adverse drug event crisis in the US today which claims a life every 5 minutes and causes billions of preventable healthcare costs.
YouScript’s CEO Kristine Ashcraft is part of the global advisory network to develop innovative and meaningful connections and solutions for some of healthcare’s biggest challenges. HealthXL created a network of incubation, live events, and a platform on equal ground from new ventures to established players in healthcare.
“Although our technology has been shown to reduce readmissions, ER visits, and deliver cost savings in as little as 60-days, YouScript’s challenge lies in reaching the right stakeholders in a complex system. HealthXL helps us reach thought leaders that are adopting solutions that help them meet the Triple Aim,” said Ashcraft. “I am very excited to join HealthXL and develop meaningful partnerships with these leaders in healthcare.”
Starting initially as an accelerator program, HealthXL connects payors, technology solution providers, device manufacturers, health providers, and other industry professionals with a platform to engage in information exchange. By utilizing this shared platform, companies can identify leaders, innovators, and investors.
HealthXL partners and key members:
- Cleveland Clinic
- Highmark Health
- Johnson & Johnson
Ashcraft is using the network to connect with key industry leaders to bring YouScript’s solutions to their problems, and finding new resources to solve challenges YouScript faces. “HealthXL provides us the opportunity to make connections that will greatly aid in our capacity to improve patient care and bend the healthcare cost curve as the benefits of precision medicine are realized in the market,” said Ashcraft.